Sources & References

79 published sources for Schnitzler Syndrome, each with evidence grades and key findings.

clinical

2 sources

Grade CreviewUnverified

Acquired autoinflammatory disorders: a dermatologist's perspective.

Bishnoi A, Sharma A, Baskaran N, Mehta H, Chatterjee D, Vinay K · Clin Exp Dermatol · 2025

  • Comprehensive dermatology review of acquired autoinflammatory disorders including Schnitzler syndrome, AOSD, VEXAS, Kikuchi-Fujimoto disease, and HLH
  • Schnitzler syndrome presented as a paradigm of acquired autoinflammatory disease with multifactorial pathogenesis
  • Distinguishes autoinflammatory disorders from connective tissue diseases by negative ANA
  • Highlights expanding genetic spectrum of acquired autoinflammatory disorders since VEXAS description
  • Cutaneous manifestations are often the earliest diagnostic clue; detailed histopathologic classification provided

treatment

31 sources

Grade Ccase reportn=1Unverified

Tinea labialis in a patient with Schnitzler syndrome on interleukin-1 receptor antagonist.

Mooney N, Grewal A, Pei S, Bogner P, Kuraitis D · JAAD Case Rep · 2025

  • First reported case of tinea labialis (oral dermatophyte infection) in a Schnitzler syndrome patient on anakinra
  • Highlights fungal infection as an infectious complication of IL-1 receptor antagonist therapy
  • Underscores importance of dermatologic monitoring during long-term anakinra treatment
  • From Roswell Park Comprehensive Cancer Center, Buffalo, NY
Grade DletterUnverified

Letter to the editor - "Re: Tinea labialis in a patient with Schnitzler syndrome on interleukin-1 receptor antagonist".

Velusamy B, Pincelli T, Sokumbi O · JAAD Case Rep · 2025

  • Expert commentary from Mayo Clinic dermatologists on anakinra-associated fungal infection risk
  • Contextualises tinea labialis as rare but clinically important opportunistic infection during IL-1 blockade
  • Supports surveillance for dermatophyte infections in Schnitzler syndrome patients on IL-1 inhibitors

diagnostics

14 sources

Grade DletterUnverified

Monoclonal gammopathies of cutaneous significance: A nomenclature and pathophysiology-based classification.

Mir TH, Patell R, Freed JA · J Am Acad Dermatol · 2026

  • Proposes nomenclature framework for monoclonal gammopathies of cutaneous significance (MGCS)
  • Classifies Schnitzler syndrome within pathophysiology-based MGCS taxonomy
  • Distinguishes Schnitzler syndrome from other MGCS including POEMS, TEMPI, and scleromyxedema
  • Supports standardised language to improve recognition and reporting of Schnitzler syndrome
Grade Ccase reportn=1Unverified

Differential Diagnosis of Chronic Spontaneous Urticaria.

Gialama D, Bonnekoh H, Rothermel ND, Oldenburg R, Khan DA, Hoffman HM, Lang D, Kolkhir P · J Allergy Clin Immunol Pract · 2025

  • Identifies key red flags distinguishing Schnitzler syndrome from chronic spontaneous urticaria: wheals lasting >24 hours, post-inflammatory hyperpigmentation, arthralgia, fever, elevated CRP
  • Recommends serum immunofixation electrophoresis and genetic testing when red flags are present
  • Discusses autoinflammatory, autoimmune, and malignant causes of chronic recurrent wheals
  • From Charité Berlin group; highlights role of histology and laboratory work-up in differential diagnosis
  • Case-based approach to DDx including Schnitzler syndrome and urticarial vasculitis
Grade CreviewUnverified

[What is an undifferentiated systemic autoinflammatory disease in adults? Current state of knowledge and practical approach].

Mertz P, Chauffier J, Delplanque M · Rev Med Interne · 2025

  • French-language review of undifferentiated systemic autoinflammatory diseases (SAIDs) in adults
  • Discusses innate immunity dysregulation and differential diagnosis including Schnitzler syndrome
  • Provides practical diagnostic approach to distinguishing undifferentiated SAID from defined entities
  • Relevant to Schnitzler syndrome evaluation in patients without classic gammopathy

genetics

8 sources

epidemiology

4 sources

Grade Bcohort studyn=306Unverified

Systemic autoinflammatory disease diagnoses in a single year from a UK national referral centre.

Caterson HC, Papadopoulou C, Peet C, Lachmann HJ · Rheumatology (Oxford) · 2025

  • 306 patients referred to UK national SAID centre in 2022; 121 (39.5%) received a SAID diagnosis
  • Median diagnostic delay for late-adult-onset SAIDs (including Schnitzler) was 6 years (IQR 2–8.5 years)
  • Late-adult-onset SAIDs median age at diagnosis 65 years (IQR 57.75–74.25); predominantly new diagnoses
  • Confirms significant underdiagnosis and delay for adult-onset autoinflammatory conditions
  • Genetic testing with 24-gene NGS panel supported diagnosis in 49% of SAID patients

reviews

6 sources

pathogenesis

3 sources

Grade Csystematic reviewUnverified

Neutrophilic Urticarial Dermatosis: A Window into Systemic Inflammation and Autoimmune Disorders.

Cai X, Zheng Y, Yang C, Xu J, Fang H, Qiao J · Clin Rev Allergy Immunol · 2025

  • Comprehensive review of neutrophilic urticarial dermatosis (NUD) across five major conditions: Schnitzler syndrome, Still's disease, CAPS, SLE, and VEXAS syndrome
  • Proposes a diagnostic framework for NUD with skin biopsy as the central tool
  • Discusses neutrophilic epitheliotropism as a histological hallmark in Schnitzler syndrome
  • NUD may serve as an early cutaneous indicator of occult systemic autoinflammatory disease
  • Multidisciplinary assessment recommended for definitive diagnosis of underlying etiology

pathophysiology

8 sources

case reports

3 sources